Loteprednol Etabonate Versus Vehicle for the Treatment of Inflammation and Pain Following Cataract Surgery
Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
This study is being conducted to compare the safety and efficacy of loteprednol etabonate
compared to vehicle for the treatment of postoperative inflammation and pain following
cataract surgery.